Valsartan and Hydrochlorothiazide Tablets, USP 80/12.5 mg, (a) 90-count bottle (NDC 0378-6321-77), (b) 500-count bottles (NDC 0378-6321-05), Rx Only, Made in India, Manufactured for: Mylan Pharmaceuticals, Inc., Morgantown, WV 26505 U.S.A.
Published December 19, 2018 · Recall initiated: December 4, 2018
Summary
FDA records drug Class II recall D-0328-2019, published December 19, 2018 and initiated December 4, 2018. Recalling firm: Mylan Laboratories Limited, (Nashik FDF); Status: Ongoing; Reported quantity: 32,696 HDPE bottles; Lot: Lot numbers: 3084363, 3084364, 3093800, 3084363, 3093800. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
GCMP Deviations: FDA analysis confirmed presence of trace amounts of an impurity, N-nitrosodiethylamine (NDEA) found in the API used to manufacture the product.
What to do
Voluntary: Firm initiated · Press Release
Get an email if VALSARTAN AND HYDROCHLOROTHIAZIDE has another recall
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Brand
- VALSARTAN AND HYDROCHLOROTHIAZIDE
- Manufacturer
- Mylan Laboratories Limited, (Nashik FDF)
- Distributor
- Product was distributed throughout the United States to several major distributors, including Puerto Rico.
- UPC
- 0303786323777
- Lot
- Lot numbers: 3084363, 3084364, 3093800, 3084363, 3093800
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- India
Related recalls
- FDAValsartan and Hydrochlorothiazide Tablets, USP 320/25 mg, (a) 90-count bottle (NDC 0378-6325-77), (b)December 19, 2018
- FDAValsartan and Hydrochlorothiazide Tablets, USP 160/25 mg, (a) 90-count bottle (NDC 0378-6323-77), (b)December 19, 2018
- FDAValsartan and Hydrochlorothiazide Tablets, USP 160/12.5 mg, (a) 90-count bottle (NDC 0378-6322-77), (b)December 19, 2018
- FDAValsartan and Hydrochlorothiazide Tablets, USP, 320 mg/25 mg, (a) 500-count bottle, Rx Only, Made in India,December 19, 2018
- FDAValsartan Tablets, USP 320 mg, 90-count bottles, Rx Only, Made in India, Manufactured for: MylanDecember 19, 2018
- FDAValsartan Tablets, USP 160 mg, 90-count bottles, Rx Only, Made in India, Manufactured for: MylanDecember 19, 2018
Questions about this recall
Was Valsartan and Hydrochlorothiazide Tablets, USP 80/12.5 mg, (a) 90-count bottle (NDC 0378-6321-77), (b) 500-count bottles (NDC 0378-6321-05), Rx Only, Made in India, Manufactured for: Mylan Pharmaceuticals, Inc., Morgantown, WV 26505 U.S.A. recalled?
Yes. FDA published recall D-0328-2019 on December 19, 2018. Reported hazard: GCMP Deviations: FDA analysis confirmed presence of trace amounts of an impurity, N-nitrosodiethylamine (NDEA) found in the API used to manufacture the product.
What should I do if I have this product?
Voluntary: Firm initiated · Press Release
How do I know if my unit is part of the recall?
Compare your product details with the notice. Brand: VALSARTAN AND HYDROCHLOROTHIAZIDE. UPC: 0303786323777.